Estrogen receptor subtype ratio change protects against podocyte damage.

Paola Catanuto, Xiaomei Xia, Simone Pereira-Simon, Sharon Elliot

Open access · greenAbstract read

In one paragraph

Article in Current trends in endocrinology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

0.9field-weighted citation impact, top 20% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

Estrogen and estrogen receptors in kidney diseases.Renal failure · 2021
Review
Centrality Analysis of Protein-Protein Interaction Networks and Molecular Docking Prioritize Potential Drug-Targets in Type 1 Diabetes.Iranian journal of pharmaceutical research : IJPR · 2020
Article
Preventative effects of resveratrol and estradiol on streptozotocin-induced diabetes in ovariectomized mice and the related mechanisms.PloS one · 2018
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Paola CatanutoDepartment of Surgery, Leonard M Miller School of Medicine, University of Miami, Miami, Florida, USA.

Xiaomei XiaDivision of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Leonard M Miller School of Medicine, University of Miami, Miami, Florida, USA.

Simone Pereira-SimonDepartment of Surgery, Leonard M Miller School of Medicine, University of Miami, Miami, Florida, USA.

Sharon ElliotDepartment of Surgery, Leonard M Miller School of Medicine, University of Miami, Miami, Florida, USA.

University of Miami · US

Funding

ESTROGEN DEFICIENCY AND RENAL DISEASE IN AGING WOMENR01AG017170 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ELLIOT, SHARON J · 1999 to 2012

$4.6M

NIA NIH HHS R01 AG017170

6 · The paper itself

Abstract

Women are relatively protected against the development and progression of glomerulosclerosis (GS) prior to menopause. However, the "female advantage" is lost in women who are either diabetic, post-menopausal or both. We showed that 17β-estradiol (E

Indexed as

diabetic glomerulosclerosisestrogen receptorpodocytesresveratrol

Identifiers

PMID29367812

PMCPMC5777622

OpenAlexW2980475173

What OpenQuestion holds

Textmetadata

LicenceTDM

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.